FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to plant-based drugs with an apparent healing, anti-inflammatory effect. Wound-healing anti-inflammatory ointment containing the following ratio of components, mass %: culture fluid of the tea fungus – 66.71; crystal gelatin – 2.15; benzocaine – 0.36; almond oil – 5.14; glycerol – 22.54, essential oil of the tea tree – 0,24; lecinol – 2.86.
EFFECT: above-described ointment has an apparent wound-healing, anti-inflammatory, regenerative effect in the absence of an allergic reaction.
1 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-BURN AGENT BASED ON ASPEN LEAVES, FLOWERS OF CALENDULA, WILD CAMOMILE | 2016 |
|
RU2618087C1 |
WOUND HEALING OINTMENT BASED ON GARDEN CABBAGE (BRASSICA OLERACEA) | 2018 |
|
RU2695349C1 |
OINTMENT CONTAINING 5% OF SAINFOIN MILK VETCH DRY EXTRACT | 2000 |
|
RU2189809C2 |
WOUND HEALING GEL FOR EXTERNAL APPLICATION | 2015 |
|
RU2603459C1 |
MILK-WAX WALNUT AND BUCKEYE OINTMENT | 2011 |
|
RU2448683C1 |
CREAM FOR TREATMENT OF INFLAMMATORY DISEASES OF THE SKIN | 2022 |
|
RU2792058C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF WOUNDS AND BURNS | 2016 |
|
RU2636530C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION FOR TREATMENT OF SKIN DISEASES | 2014 |
|
RU2567730C1 |
Authors
Dates
2018-03-15—Published
2017-02-28—Filed